We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Biomarkers May Predict Course of Breast Cancer

By HospiMedica staff writers
Posted on 07 Feb 2002
An analysis of two biomarkers has demonstrated that, apart from lymph node status, high levels of the markers were the strongest predictors of poor relapse-free survival and poor overall survival of women with breast cancer. More...
The analysis was conducted by researchers at the University Hospital Rotterdam (The Netherlands) on behalf of the European Organization for Research and Treatment of Cancer-Receptor and Biomarker Group. The results were reported in the January 16, 2002, issue of the Journal of the National Cancer Institute.

The biomarkers, urokinase-type plasminogen activator (uPA) and its inhibitor ( PAI-1), have essential roles in tumor invasion and metastasis. High levels are associated with poor prognosis in breast cancer patients. After the researchers analyzed patient data from more than 8,000 primary breast cancer tumors, they concluded that for patients with lymph-node-negative breast cancer, measurements of the two markers in primary tumors may help doctors better understand the course of the disease and enable them to design individualized treatment strategies.

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Patient Preoperative Skin Preparation
BD ChloraPrep
Medical-Grade Display
HL2316SHTB
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.